Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age
Author(s) -
Claire Dinsdale,
Mushtaq Ahmad Wani,
John Steward,
M. S. O'Mahony
Publication year - 2005
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afi104
Subject(s) - medicine , spironolactone , tolerability , heart failure , adjunctive treatment , cardiology , adverse effect
395 5. Shinkawa A, Ueda K, Kiyohara Y et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995; 26: 380–5. 6. Ezekowitz M, James K, Nazarian S et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 1995; 92: 2178–82. 7. Kilander L, Andren B, Nymanet H et al. Atrial fibrillation is an independent determinant of low cognitive function: a crosssectional study in elderly men. Stroke 1998; 29: 1816–20. 8. Sabatini T, Frisoni G, Barbisoni P et al. Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc 2000; 48: 387–90. 9. Ott A, Breteler M, de Bruyne M et al. Atrial fibrillation and dementia in a population-based study: the Rotterdam study. Stroke 1997; 28: 316–21. 10. Farina E, Magni E, Ambrosini F et al. Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurol Scand 1997; 96: 310–16. 11. Stanley TO, Mackensen B, Grocott H et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002; 94: 290–5. 12. Sudlow M, Thomson R, Thwaites B et al. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167–71. 13. O’Connell J, Gray C, French J et al. Atrial fibrillation and cognitive function: case-control study. J Neurol Neurosurg Psychiatry 1998; 65: 386–9. 14. Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992; 30: 473–83. 15. Stanford/VA Alzheimer’s Disease Research Center, Geriatric Depression Scale 2003. 16. Agüero-Torres H, Fratiglioni L, Guo Z et al. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol 1999; 58: 737–48. 17. Eagles J, Beattie J, Restall D et al. Relation between cognitive impairment and early death in the elderly. BMJ 1990; 300: 239–40. 18. Gussekloo J, Westendorp R, Remarque E et al. Impact of mild cognitive impairment on survival in very elderly people: cohort study. BMJ 1997; 315: 1053–4. 19. Brayne C, Best N, Muir M et al. Five-year incidence and prediction of dementia and cognitive decline in a population sample of women aged 70–79 at baseline. Int J Geriatr Psychiatry 1997; 12: 1107–18. 20. O’Brien JT, Erkinjuntti T, Reisberg B. Vascular cognitive impairment. Lancet 2003; 2: 89–98. 21. Elias MF, Sullivan LM, D’Agostino RB et al. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004; 35: 404–9.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom